Time from melanoma diagnosis to surgery is commonly delayed in Medicare patients

the ONA take:

Surgery is delayed in 1 in 5 Medicare patients with melanoma, according to a Yale study. Melanoma is the leading cause of new cancer diagnoses in the United States.

In this population-based analysis of delay of surgery among Medicare patients with melanoma, culled from the Surveillance, Epidemiology, and End Result-Medicare database, the researchers reviewed more than 32,000 cases of melanoma diagnosis in Medicare patients.

No gold standard exists on time from diagnosis to study; however, the recommended timeframe from between diagnosis and surgery is less than 6 weeks.

This study found that 22% of patients waited longer than 1.5 months for surgery, and surgery was delayed more than 3 months in 8% of patients. Delays were most common when the treating clinician was not a dermatologist (eg, a primary care physician or general surgeon).

In addition, study findings revealed a significant difference in timing from melanoma diagnosis to surgery for Medicare patients.

The researchers suggest further studies should seek to identify reasons for the delay to surgery and to consider how coordination between care providers can be improved.

Time from melanoma diagnosis to surgery is commonly delayed in Medicare patients
Surgery is delayed in 1 in 5 Medicare patients with melanoma.
One in five Medicare patients with melanoma experience delays in getting surgery, a Yale study found. The research was published April 8 in JAMA Dermatology.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs